Safety and immunogenicity of Clostridium difficile toxoid vaccine in Japanese adults

This was a randomized, placebo-controlled, Phase I/II study conducted in a Japanese cohort to assess the safety and immunogenicity of Clostridium difficile vaccine (the same formulation as that used in the ongoing global Phase III study). Healthy Japanese adults aged 40–75 years were randomized to r...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Hum Vaccin Immunother
Päätekijät: Matsuoka, Osamu, Patel, Dhaval M., Sasaki, Shin, Oka, Hayato, Sasaki, Toru, Pietrobon, Patricia J., Laot, Thelma, Bouckenooghe, Alain, Menezes, Josemund, de Bruyn, Guy
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Taylor & Francis 2017
Aiheet:
Research Paper
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC5806652/
https://ncbi.nlm.nih.gov/pubmed/29116880
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/21645515.2017.1395538
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia